Covered recipient · General Payments record
KAMAL PRASAD SHARMA
Allopathic & Osteopathic Physicians Pediatrics Pediatric Critical Care Medicine
General Payments · PY2019–2024
$956.00
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $308.26 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $92.66 | 4 |
| EISAI INC. | $69.74 | 3 |
| Gilead Sciences, Inc. | $27.03 | 1 |
| GENZYME CORPORATION | $26.01 | 1 |
| Alnylam Pharmaceuticals Inc. | $21.39 | 1 |
| SHIELD THERAPEUTICS INC | $21.05 | 1 |
| SOBI, INC | $17.65 | 1 |
| E.R. Squibb & Sons, L.L.C. | $17.52 | 1 |
| TAIHO ONCOLOGY, INC. | $15.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc. | $21.39 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125824676 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.52 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101324776 | CMS |
| Eisai Inc. | $23.31 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110757118 | CMS |
| Eisai Inc. | $22.76 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110757120 | CMS |
| Eisai Inc. | $23.67 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110757122 | CMS |
| GENZYME CORPORATION | $26.01 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139909441 | CMS |
| Gilead Sciences, Inc. | $27.03 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133835110 | CMS |
| GlaxoSmithKline, LLC. | $23.14 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116542132 | CMS |
| GlaxoSmithKline, LLC. | $22.66 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116041454 | CMS |
| GlaxoSmithKline, LLC. | $20.16 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116533868 | CMS |
| GlaxoSmithKline, LLC. | $26.70 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116348544 | CMS |
| SHIELD THERAPEUTICS INC | $21.05 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150152954 | CMS |
| SOBI, INC | $17.65 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141441283 | CMS |
| TAIHO ONCOLOGY, INC. | $15.21 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137939522 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.